Remote Field Account Specialist – CNS Pharma

Praxis Precision Medicines, Inc.; United States; Remote; USD 160,000 - 192,000; Full time

Job summary

Praxis Precision Medicines, Inc. is seeking an Account Specialist to execute in the field across a defined territory, build strong relationships with healthcare providers, and drive commercial performance in a remote-based role with travel.

You will collaborate with Market Access, Patient Services, and Medical teams to support launches, adoption, and patient access, while maintaining product and disease state knowledge.

Qualifications

• 5+ years of direct sales in CNS or specialty pharmaceuticals.
• Knowledge of complex patient pathways and prescriber dynamics.
• Experience with product launches, including pre-launch planning and early market execution.
• Experience selling into hospital systems, IDNs and institutional accounts is a plus.

Responsibilities

• Execute territory business plans to achieve and exceed sales goals.
• Develop and maintain strong relationships with healthcare providers and key stakeholders.
• Drive product adoption through effective customer engagement and education.
• Navigate complex patient pathways and support access to therapy.
• Partner with Market Access, Strategic Accounts, Patient Services, and Medical teams to optimize customer and patient outcomes.
• Support launch execution, including pre-launch planning and post-launch adoption strategies.
• Leverage field insights to inform strategy and improve execution.
• Maintain a high level of product, disease state, and market knowledge.

Skills

CNS sales

Pharma sales

Account management

Hospital/IDN sales

Job description

Praxis Precision Medicines, Inc. is seeking an Account Specialist to execute in the field across a defined territory, build strong relationships with healthcare providers, and drive commercial performance in a remote-based role with travel.

You will collaborate with Market Access, Patient Services, and Medical teams to support launches, adoption, and patient access, while maintaining product and disease state knowledge.